BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16678567)

  • 1. Design of treatment trials for functional gastrointestinal disorders.
    ; Irvine EJ; Whitehead WE; Chey WD; Matsueda K; Shaw M; Talley NJ; Veldhuyzen van Zanten SJ
    Gastroenterology; 2006 Apr; 130(5):1538-51. PubMed ID: 16678567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of Treatment Trials for Functional Gastrointestinal Disorders.
    Irvine EJ; Tack J; Crowell MD; Gwee KA; Ke M; Schmulson MJ; Whitehead WE; Spiegel B
    Gastroenterology; 2016 May; 150(6):1469-1480.e1. PubMed ID: 27147123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case study comparing a randomized withdrawal trial and a double-blind long-term trial for assessing the long-term efficacy of an antidepressant.
    Mallinckrodt C; Chuang-Stein C; McSorley P; Schwartz J; Archibald DG; Perahia DG; Detke MJ; Alphs L
    Pharm Stat; 2007; 6(1):9-22. PubMed ID: 17238129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study design for the evaluation of treatment.
    Morales AJ
    Semin Reprod Endocrinol; 1996 May; 14(2):111-8. PubMed ID: 8796933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature.
    Scales CD; Norris RD; Keitz SA; Peterson BL; Preminger GM; Vieweg J; Dahm P
    J Urol; 2007 Mar; 177(3):1090-4; discussion 1094-5. PubMed ID: 17296417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
    Lizogub VG; Riley DS; Heger M
    Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical development paradigm for cancer vaccines and related biologics.
    Hoos A; Parmiani G; Hege K; Sznol M; Loibner H; Eggermont A; Urba W; Blumenstein B; Sacks N; Keilholz U; Nichol G;
    J Immunother; 2007 Jan; 30(1):1-15. PubMed ID: 17198079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
    Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of reporting of randomized, controlled trials in cerebral palsy.
    Anttila H; Malmivaara A; Kunz R; Autti-Rämö I; Mäkelä M
    Pediatrics; 2006 Jun; 117(6):2222-30. PubMed ID: 16740868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic gastropathy and prokinetics.
    Talley NJ
    Am J Gastroenterol; 2003 Feb; 98(2):264-71. PubMed ID: 12591039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The trials and tribulations of drug development for functional gastrointestinal disorders.
    Chang L
    Neurogastroenterol Motil; 2008 May; 20 Suppl 1():130-8. PubMed ID: 18402650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing a decision-theoretic design in clinical trials: why and how?
    Palmer CR; Shahumyan H
    Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intention-to-treat analysis in clinical trials: principles and practical importance.
    Soares I; Carneiro AV
    Rev Port Cardiol; 2002 Oct; 21(10):1191-8. PubMed ID: 12522981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodologic recommendations for cocaine abuse clinical trials: a clinician-researcher's perspective.
    Nunes EV
    NIDA Res Monogr; 1997; 175():73-95. PubMed ID: 9467793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in drug development for functional gastrointestinal disorders. Part I: functional dyspepsia.
    Andresen V; Camilleri M
    Neurogastroenterol Motil; 2006 May; 18(5):346-53. PubMed ID: 16629861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.